Login

Mauricio Gutierrez, CEO of NRG Energy, champions sustainable practices and green power initiatives in his leadership role. 00:10:00

Share On Facebook Share On Twitter

Mauricio Gutierrez, CEO of NRG Energy

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Introducing Blue Trust | Bethany Frymire, Financial Advisor at Blue Trust
00:10:00
Norwell-based Clean Harbors CEO is featured on 'Undercover Boss' showcasing corporate leadership and operations.
00:10:00
Navigating Investment Protection in Renewable Energy | Georg Hotar, CEO , Photon Energy NV .
00:10:00
Exploring IDIS Wall Station: Monitoring, Export Management & Integration | Y.D. Kim - CEO of Intelligent Digital Integrated Security Co.,Ltd.
00:10:00
Driving Growth: Strategies and Innovations in Private Markets | Orlando Bravo, Founder, Thoma Bravo.
00:00:00
Diamyd Medical | interview with CEO Ulf Hannelius
00:00:00
Faron Pharmaceuticals outlines groundbreaking work in cancer treatment - Markku Jalkanen, CEO of Faron Pharmaceuticals Limited
00:10:00
Diversifying Wealth: Srikanth Narayan on Managing Concentrated Stock with Exchange Funds
00:10:00
McFarlane Lake Mining CEO Mark Trevisiol discusses plans for exploration and development of gold properties in Canada, including an upsized private placement for further exploration near Ontario/Manitoba border.|Mark Trevisiol President, CEO of McFarlane
00:10:00
The president of The Musuneggi Financial Group leads a financial advisory firm affiliated with Grove Point Investments, LLC and Grove Point Advisors, LLC.
00:10:00
Exploring Hotel Real Estate Investing with Mark Brugger: Building, Strategies, Teams, and Acquisitions | Mark Brugger, CEO ,Diamondrock Hospitality Co.
00:10:00
Detailed Explanation of the Zero Trip Wedge and Its Evolution

© 2026 Nehu